2025年的议程
CHI第三届年度会议
Clinical Trial Venture, Innovation & Partnering
临床试验风险投资、创新和合作伙伴关系
Accelerating Innovation, Accessibility and Scale
加速创新可及性规模
2025年2月4日～5日（所有时间均为美国东部标准时间）
2025年2月4日（星期二）
Registration Open
Organizer's Welcome Remarks
Identifying and Addressing Pharma's Unmet Needs: Strategic Insights for Investment
Jodi Akin, Founder, Hawthorne Health
This panel will examine key challenges and unmet needs in the pharmaceutical industry. Attendees will gain an understanding of clinical operational demands and innovation opportunities, helping them make informed investment decisions. The discussion will bridge clinical operations and investment strategies, highlighting trends and high-potential opportunities in the evolving clinical trial landscape.
FIRESIDE CHAT: Driving ROI in Clinical Trials with Real-World Data Innovation
David Apfel, Executive Director, Head, External Innovation, R&D Data Science and Digital Health, Johnson & Johnson
Brigham Hyde and a pharmaceutical partner will reveal how real-world data is transforming clinical development, enabling faster, smarter decisions that reduce costs and time-to-market. By leveraging these data assets for rapid hypothesis testing, protocol optimization, and regulatory alignment, this innovation not only accelerates drug development but also offers a significant return on investment. Investors will gain insights into how these advancements create a competitive advantage in the evolving clinical trials landscape.
Start-Up Company Showcase
Shwen Gwee, Founder & Chief Disruptor, Health Disruptors, Inc.
Today’s start-ups are leveraging breakthrough technologies to innovate, automate, and revolutionize clinical trial design and efficiency, improve patient engagement, and overcome regulatory hurdles to accelerate clinical research success. This panel highlights the work of five startup technology companies and their missions to transform and advance healthcare.
Welcome Reception in the Exhibit Hall (Sponsorship Opportunities Available)
Wind down at the end of a busy session day with colleagues and old and new friends. Networking is always in full swing at this reception, so raise a glass with your favorite exhibitors and take a chance at winning one of our fabulous raffle prizes (must be present to win). Continue your networking over dinner at one of the Rosen Shingle Creek's fine dining or casual restaurants and eliminate the need to face Orlando traffic.
Close of Day
2025年2月5日（星期三）
Registration and Morning Coffee
Organizer's Welcome Remarks
KEYNOTE PRESENTATION: Shaping Tomorrow's Clinical Trial Market Today: Deal Trends and AI's Role
Shane C. Senior, Managing Director & Owner, Crosstree Capital Partners, Inc.
The clinical trial market is transforming, driven by tech-enabled services and AI. In this session, Shane, Senior, Managing Director, and Co-Founder of Crosstree, will examine how past investments and acquisitions have shaped the industry and highlight future strategic value-creation opportunities. AI is both a threat and opportunity hiding in plain sight that will influence winning and losing investment strategies. As the industry pivots towards tech and AI-integrated solutions, the future is clear: investing in tech-enabled services today is critical for staying competitive and avoiding obsolescence in the rapidly evolving landscape of clinical trials.
Where Are Investors Placing Their Bets? An Oxford-Style Debate
Jessica J. Federer, Board Member, Angelini Ventures
In a rapidly evolving clinical trial landscape, where are investors directing their capital? This dynamic panel features experts from private equity, venture capital, and corporate ventures discussing emerging trends and technologies reshaping the industry. Expect lively debates on investment strategies and the flexibility needed to adapt to market shifts, providing attendees with real-time insights into the critical factors driving investment decisions in clinical trial innovation.
Fueling Innovation: How Pharma Venture Arms Are Transforming Clinical Trials
Jeremy P. Goldberg, Operating Partner, Healthcare, Arsenal Capital Partners
This panel features leaders from the venture arms of major pharmaceutical companies and prominent investors, offering insights into how they are deploying capital to drive innovation in clinical trials. Speakers will delve into the evolving investment strategies of large pharma, highlighting specific areas of focus and examples of technology-driven advancements transforming clinical operations. This conversation will provide a unique and educational perspective on how these investments are shaping the future of clinical trial innovation
How PE Backed Site Networks are Changing the Recruitment Landscape
Networking Coffee Break
Leading the Future of Clinical Trials: CEO and Founders' Perspectives on Innovation and Transformation
Rana Lonnen, Managing Director, Novartis
This panel will feature four leading CEOs and founders discussing key challenges and high-impact innovations in clinical trial design. Topics include digital twins, process automation, and competitive data use. Learn how these leaders are driving efficiency and success while creating lucrative investment opportunities in the evolving clinical trial landscape.
Revolutionizing Clinical Trials with AI: Bridging Complexity and Speed for a New Era of InnovationNetworking Luncheon
As part of the VIP Summit, join us for a special luncheon where you can collaborate, network, and connect with industry leaders. Enjoy a relaxed environment to share insights and build relationships, all while staying in the session room for seamless participation. This is an opportunity to engage with your peers in a focused, interactive setting.
Driving Innovation in Clinical Trials: Insights for Investors from Industry Leaders
Join Julie Ross, CEO of Advanced Clinical, and Deirdre BeVard, SVP of R&D Strategic Operations at CSL, for an engaging fireside chat on the evolving landscape of clinical trials and its implications for investors. This session will explore how market shifts, regulatory changes, and innovation requirements are reshaping clinical development. Key discussion points include: Navigating new pressures such as decentralized trials, patient-centric approaches, and evolving disease profiles. Addressing the gap between market innovations and their impact on timelines.Strategies for aligning investments with emerging regulatory and market demands. Drawing from their unique perspectives-spanning contract research organizations (CROs) and pharma-Julie and Deirdre will share actionable insights into what’s driving success, where challenges remain, and how the investment community can play a pivotal role in supporting the next wave of clinical trial innovation. Perfect for investors seeking to understand the changing dynamics of clinical development and identify opportunities for impactful investment.
Unlocking Value: Transforming Clinical Business Operations with AI-Powered Solutions by Strategikon
Anca Copaescu, CEO, Strategikon Pharma
Artificial Intelligence (AI) is revolutionizing the clinical business operations landscape, enabling unprecedented levels of efficiency, transparency, and strategic insight. Strategikon showcases its cutting-edge AI-powered solutions that redefine how biopharmaceutical companies and their service providers manage outsourcing, budgeting, and vendor relationships .Attendees will gain insight into how Strategikon's innovative tools streamline complex clinical trial workflows, enhance data-driven decision-making, and accelerate development timelines, ultimately improving patient outcomes. We will demonstrate how our advanced AI capabilities not only reduce operational inefficiencies but also create tangible value by driving cost savings and improving predictability in clinical development. Join us to discover how Strategikon is shaping the future of clinical operations, delivering measurable impact for stakeholders across the biopharmaceutical ecosystem.
Roundtable Discussions are informal, moderated discussions, allowing participants to exchange ideas and experiences and develop future collaborations around a focused topic. Each discussion will be led by a facilitator who keeps the discussion on track and the group engaged. To get the most out of this format, please come prepared to share examples from your work, be a part of a collective, problem-solving session, and participate in active idea sharing.
Table: Strategies for Successful Transactions, Acquisitions, and Investments in Healthcare
Moderator: Dexter Braff, President and Founder, The Braff Group
Investing in AI for Clinical Trials: Navigating Risk and Maximizing ROI
Mitesh Rao, MD, Founder & CEO, OMNY
AI is transforming clinical trials, but understanding the investment landscape is crucial. This panel, featuring experts from venture capital, pharma, and healthcare, will explore key factors in AI investments for clinical trial technologies. Topics include data deployment, infrastructure challenges, and cybersecurity risks. Gain valuable insights to assess the true potential of AI-driven solutions and make informed investment decisions that balance risk with ROI.
Visionary Leadership in Clinical Trial Innovation: A Fireside Chat with Miruna Sasu
Miruna Sasu, President and CEO, COTA, Inc.
Join us for an inspiring fireside chat with Miruna Sasu, Chief Executive Officer at COTA and a trailblazer in life sciences innovation. With decades of leadership experience at top-tier organizations like Johnson & Johnson and Bristol-Myers Squibb, Miruna has revolutionized the integration of real-world data and digital strategies to accelerate drug development.This engaging conversation will explore her transformative journey, the promise of real-world data in oncology, and the strategic mindset needed to drive scalable innovation. Miruna’s passion for mentoring future leaders and advancing patient outcomes will energize and challenge investors to reimagine the potential of clinical trial technology.Discover the opportunities to invest in visionary solutions that bridge cutting-edge technology and meaningful healthcare advancements. Let this session inspire your investment strategies and empower women in leadership to shape the future of clinical trial innovation.
Unlocking the Patient Recruitment Puzzle: A Smart Investment in Enhancing the Patient Experience and the Future of Trials
Laura Y. Hilty, Principal, Investments & Growth, HealthX Ventures
Patient recruitment remains one of the biggest challenges in clinical trials, but where are the real opportunities? This panel will dive into the latest strategies and innovations in patient recruitment, uncovering what’s actually driving success. We'll explore the market potential of these approaches and assess whether investing in patient recruitment technologies and solutions could be a game-changing move for investors seeking long-term value in the clinical trial landscape.
Close of Summit
* 活动内容有可能不事先告知作更动及调整。